Why Ulta Beauty (ULTA) is a Top Stock for the Long-Term

Zacks reports that Ulta Beauty shares rose 233.14% from the Focus List addition price of $177.59 on March 25, 2020, to $591.70. For fiscal 2027, 13 analysts raised estimates in the last 60 days, lifting the consensus estimate by $0.19 to $28.95; Zacks also cites a 7.6% average earnings surprise and expected current-year earnings growth of 12.9%. Despite the positive outlook and historical share gain, ULTA carries a Zacks Rank of #3 (Hold).

Analysis

The investable signal is estimate momentum, not the promotional Focus List track record. Positive revisions can reinforce near-term earnings expectations, but without revision magnitude versus the prior base, company guidance, and current valuation, they do not establish that upside is mispriced. The article’s own rating has already moved to neutral territory; treat that as a reason not to chase rather than as a short signal.

For ULTA, the key second-order question is whether growth converts to profitable transactions rather than being bought through promotions, loyalty rewards, or higher customer-acquisition costs. Beauty may be relatively resilient, but value-seeking shoppers can shift baskets toward mass channels while prestige brands and Sephora compete for the same customer. Watch comparable sales, transaction frequency, gross margin, and inventory—not headline EPS revisions alone. These are hypotheses to test against results, not claims established by this article.

Near term, this is weak catalyst information and may have little price impact. Over 1–3 months, a sustained, broadening estimate-revision trend plus resilient comps and margins would support earnings momentum; downward guidance revisions or margin pressure would invalidate it. Over 6–18 months, channel substitution and promotional intensity are the more important structural risks. The source mixes a historical performance window with forward estimates; verify publication date, price basis, and current consensus before acting. Contrarian read: the retrospective winner framing risks encouraging extrapolation after substantial past appreciation, while the modest revision signal may already be reflected in expectations.

Key Decisions for Investors

• No fresh directional position on this article alone. Do not treat the Focus List history or past share appreciation as evidence of current expected return.
• Alert/watch: verify the latest ULTA consensus EPS, revision breadth and magnitude, management guidance, and the dates behind the quoted share price and estimates; reassess only if revisions persist and operating metrics confirm them.
• For an existing long, monitor comparable-sales growth alongside gross margin and promotional intensity. Repeated guidance cuts, weakening transaction trends, or margin compression would falsify the momentum thesis and warrant reducing exposure.
• Track competitive substitution from Sephora, prestige-brand direct channels, and mass retail. Evidence of share loss or rising promotional needs would favor avoiding ULTA versus the beauty-retail peer group; no pair trade is justified without current relative valuation and operating data.